# Jasper Therapeutics, Inc.: Form DEF 14A, filed Apr 29, 2022

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: DEF 14A
- Filed: 2022-04-29
- Accepted by EDGAR: Apr 29, 2022, 16:01 ET
- Period: 2022-06-23
- Accession: 0001213900-22-022704
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390022022704/def14a0422_jasperthera.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390022022704/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390022022704/def14a0422_jasperthera.htm

Filed Apr 29, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-022704. Last ingested by Listed: Nov 4, 2026, 08:12 ET. No prices; not investment advice.